You Searched For:

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

LABORATORY CHECKLIST Microbiology ☐ Agars ☐ Air Samplers ☐ Anaerobic Chambers ☐ Antisera ☐ ATP Bioluminescence Systems ☐ Autoclave Assurance Products ☐ Autoclaves/Sterilizers ☐ Bags 95kPa Autoclavable Biohazard Sample/Specimen Stomacher ☐ Balances...

LABORATORY CHECKLIST Microbiology ☐ Agars ☐ Air Samplers ☐ Anaerobic Chambers ☐ Antisera ☐ ATP Bioluminescence Systems ☐ Autoclave Assurance Products ☐ Autoclaves/Sterilizers ☐ Bags 95kPa Autoclavable Biohazard Sample/Specimen Stomacher ☐ Balances...

General Description of an Application Application Date: 09.08.2013 Page 1 of 8 Water determination according to Karl Fischer in organic liquids Application Date: 09.08.2013 Page 2 of 8 Use This method is a general description how to determine the ...

General Description of an Application Application Date: 09.08.2013 Page 1 of 8 Water determination according to Karl Fischer in organic liquids Application Date: 09.08.2013 Page 2 of 8 Use This method is a general description how to determine the ...

General Description of an Application Application Date: 09.08.2013 Page 1 of 8 Water determination according to Karl Fischer in organic liquids Application Date: 09.08.2013 Page 2 of 8 Use This method is a general description how to determine the ...

COL06001-CFS-Aseptic-Filling-Brochure-02-26-18.indd Nunc Cell Factory systems Ready set connect: aseptic filling made easy 2 More confidence helps reduce risk Themo Scientific™ Nunc™ Cell Factory™ multilayer systems are designed for a variety of b...

General Description of an Application Application Date: 09.08.2013 Page 1 of 8 Water determination according to Karl Fischer in organic liquids Application Date: 09.08.2013 Page 2 of 8 Use This method is a general description how to determine the ...